Humacyte Inc. (NASDAQ: HUMA) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT HUMACYTE INC.

Humacyte Inc. (NASDAQ: HUMA)
Listen to this Section


$1.37
-0.1250 ( -8.39% ) 4.7M

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.

Clinical Trial Pipeline Stages


Drug Name Stage
Human Acellular Vessel (HAV)DetailsDialysis access (AV access) Phase 3
Humacyte Acellular Tissue Engineered Vessel (ATEV™)DetailsDialysis access (AV access) Phase 3

Market Data


Open $1.37
Previous Close $1.49
Volume 4.7M
Market Cap $310.83M
Day Range $1.36 - $1.52
52 Week Range $0.55 - $2.93
Shares Outstanding 222.02M
Change % -8.39%
Net Change ▼ -0.1250
Insider Ownership -0.25%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2021
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -11,429,032.00

Date Type Amount Purchased Purchaser
2023-12-12 Sale -301000.00 Sander Dale A.
2023-12-12 Sale -210000.00 Cao Yang
2023-12-12 Sale -290000.00 Prichard Heather Ledbetter
2023-12-12 Sale -276000.00 Scheessele William John
2023-11-21 Sale -6564.00 Wallace Max N.
2023-10-10 Sale -114420.00 Niklason Laura E
2023-10-10 Sale -114420.00 Dougan Brady W
2023-09-15 Sale -2000000.00 Niklason Laura E
2023-09-15 Sale -2000000.00 Dougan Brady W
2023-08-21 Sale -570174.00 Niklason Laura E

SEC Filings


Form Type Description Pages Date
8-k 8K-related 15 Nov 12, 2025
10-q Quarterly Reports 131 Nov 12, 2025
8-k 8K-related 22 Oct 07, 2025
8-k 8K-related 170 Sep 18, 2025
4 Insider transactions 1 Aug 20, 2025
4 Insider transactions 1 Aug 20, 2025
10-q Quarterly Reports 83 Aug 11, 2025
8-k 8K-related 15 Aug 11, 2025
4 Insider transactions 1 Jun 16, 2025
4 Insider transactions 1 Jun 16, 2025

Latest News


× Before browsing our site, please accept our cookies policy